Heart failure and treatment: part 1.
Diagnosis of heart failure is increasingly prevalent. Each year, 550,000 new cases are anticipated. To provide quality outcomes, nurses and physicians must understand the etiology and pathophysiology of heart failure. Research into heart failure provides information about treatment and drug therapies that reduce heart failure symptoms and improve quality of life. PACU nurses care for heart failure patients in various stages of this syndrome. Determining the plan of care for this high acuity population requires nurses with skills to manage complex patients in the perianesthesia period.
Gilmore
Janet C
JC
The Methodist Hospital, Texas Medical Center, Houston, TX 77030, USA. jgilmore@tmh.tmc.edu
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000627:therapeutic use; D015984:Causality; D004232:Diuretics / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D006801:Humans; D010347:Patient Care Planning; D016528:Postanesthesia Nursing; D015995:Prevalence; D011788:Quality of Life; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002316:Cardiotonic Agents; D004232:Diuretics